Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals (Reprinted from Infection Control and Hospital Epidemiology, vol 18, pg 275-91, 1997)

被引:464
作者
Shlaes, DM
Gerding, DN
John, JF
Craig, WA
Bornstein, DL
Duncan, RA
Eckman, MR
Farrer, WE
Greene, WH
Lorian, V
Levy, S
McGowan, JE
Paul, SM
Ruskin, J
Tenover, FC
Watanakunakorn, C
机构
[1] VET AFFAIRS LAKESIDE MED CTR, CHICAGO, IL USA
[2] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, NEW BRUNSWICK, NJ USA
[3] WILLIAM S MIDDLETON MEM VET ADM MED CTR, MADISON, WI USA
[4] SUNY HLTH SCI CTR, SYRACUSE, NY 13210 USA
[5] LAHEY CLIN FDN, BURLINGTON, MA USA
[6] DULUTH CLIN LTD, DULUTH, MN USA
[7] ST ELIZABETH HOSP, ELIZABETH, NJ USA
[8] SUNY STONY BROOK, STONY BROOK, NY 11794 USA
[9] BRONX LEBANON HOSP CTR, BRONX, NY 10456 USA
[10] TUFTS UNIV, SCH MED, BOSTON, MA 02111 USA
[11] GRADY MEM HOSP, ATLANTA, GA USA
[12] NEW JERSEY DEPT HLTH, TRENTON, NJ USA
[13] KAISER PERMANENTE MED CTR, LOS ANGELES, CA 90034 USA
[14] CTR DIS CONTROL & PREVENT, ATLANTA, GA USA
[15] ST ELIZABETH HOSP, MED CTR, YOUNGSTOWN, OH 44501 USA
关键词
D O I
10.1086/513766
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antimicrobial resistance results in increased morbidity, mortality, and costs of health care, Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
引用
收藏
页码:584 / 599
页数:16
相关论文
共 85 条
[1]  
ACHUSIM LE, 1992, PHARMACOL THERAPEUT, V17, P775
[2]  
[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
[3]  
[Anonymous], HOSP EPIDEMIOLOGY IN
[4]  
BALLOW CH, 1992, DIAGN MICR INFEC DIS, V15, pS37
[5]   GENTAMICIN-RESISTANT MENADIONE AND HEMIN AUXOTROPHIC STAPHYLOCOCCUS-AUREUS PERSIST WITHIN CULTURED ENDOTHELIAL-CELLS [J].
BALWIT, JM ;
VANLANGEVELDE, P ;
VANN, JM ;
PROCTOR, RA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (04) :1033-1037
[6]   IMPACT OF VOLUNTARY VS ENFORCED COMPLIANCE OF 3RD-GENERATION CEPHALOSPORIN USE IN A TEACHING HOSPITAL [J].
BAMBERGER, DM ;
DAHL, SL .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (03) :554-557
[7]   CLINICAL AND MICROBIOLOGIC CONSEQUENCES OF AMIKACIN USE DURING A 42-MONTH PERIOD [J].
BERK, SL ;
ALVAREZ, S ;
ORTEGA, G ;
VERGHESE, A ;
HOLTSCLAWBERK, SA .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (03) :538-541
[8]   5-YEAR SURVEILLANCE OF AMINOGLYCOSIDE USAGE IN A UNIVERSITY HOSPITAL [J].
BETTS, RF ;
VALENTI, WM ;
CHAPMAN, SW ;
CHONMAITREE, T ;
MOWRER, G ;
PINCUS, P ;
MESSNER, M ;
ROBERTSON, R .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (02) :219-222
[9]   ANTIBIOTIC STREAMLINING FROM COMBINATION THERAPY TO MONOTHERAPY UTILIZING AN INTERDISCIPLINARY APPROACH [J].
BRICELAND, LL ;
NIGHTINGALE, CH ;
QUINTILIANI, R ;
COOPER, BW ;
SMITH, KS .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (09) :2019-2022
[10]   ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].
CHOW, JW ;
FINE, MJ ;
SHLAES, DM ;
QUINN, JP ;
HOOPER, DC ;
JOHNSON, MP ;
RAMPHAL, R ;
WAGENER, MM ;
MIYASHIRO, DK ;
YU, VL .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :585-590